Skip to content

Morgan Campbell

Substance Abuse and Mental Health Services Administration

2 papers in the library · publishing 2021-2024

Papers

Can Past Psychedelic Use Mitigate the Severity of Opioid Use Disorder?: Case Report of a Musician.

Delaware journal of public health June 1, 2024 Asim Trimzi, Morgan Campbell

A case report describes an award-winning musician with extensive early-life hallucinogen use and examines how that history influenced his overall wellbeing and subsequent opioid experience. The text notes that little is known about the link between psychedelic use and substance abuse in the general population.

The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness

Frontiers in Psychiatry July 5, 2021 Morgan Campbell, Monnica T. Williams

Patients with mental illnesses should have the same access to promising experimental therapies, including psychedelics, as patients with other conditions. The principle of early access to experimental treatments, advanced by activist Larry Kramer during the AIDS pandemic, is now standard in medicine for diseases like cancer and infectious diseases. Psychiatry has failed to provide similar expanded access during public health emergencies, psychological crises, and pandemics, despite patient preferences and community needs. The field must align with the rest of medicine and let patient preferences guide policy and law on unapproved medications such as psychedelics.